# Double Blind, Placebo-controlled Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal Women

> **NCT01041092** · PHASE4 · COMPLETED · sponsor: **Fundació Sant Joan de Déu** · enrollment: 34 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** raloxifene

## Key facts

- **NCT ID:** NCT01041092
- **Lead sponsor:** Fundació Sant Joan de Déu
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2009-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01041092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01041092, "Double Blind, Placebo-controlled Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal Women". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01041092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*